Medpace Holdings, Inc. - stock earnings
MEDP Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| July 22, 2024 BeforeMarket | - / - | 530.0 million | - / 532.4 million | 540.2 million |
MEDP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 102.6 million USD | 511.0 million USD |
| 2023Q4 | 78.3 million USD | 498.4 million USD |
| 2023Q3 | 70.6 million USD | 492.5 million USD |
| 2023Q2 | 61.1 million USD | 460.9 million USD |
| 2023Q1 | 72.9 million USD | 434.1 million USD |
| 2022Q4 | 68.7 million USD | 394.1 million USD |
| 2022Q3 | 66.0 million USD | 383.7 million USD |
| 2022Q2 | 49.3 million USD | 351.2 million USD |
| 2022Q1 | 61.3 million USD | 330.9 million USD |
| 2021Q4 | 50.0 million USD | 308.6 million USD |
| 2021Q3 | 48.6 million USD | 295.6 million USD |
| 2021Q2 | 39.9 million USD | 278.3 million USD |
| 2021Q1 | 43.3 million USD | 260.0 million USD |
| 2020Q4 | 50.9 million USD | 259.7 million USD |
| 2020Q3 | 41.5 million USD | 230.4 million USD |
| 2020Q2 | 24.1 million USD | 205.0 million USD |
| 2020Q1 | 29.0 million USD | 230.9 million USD |
| 2019Q4 | 29.8 million USD | 229.9 million USD |
| 2019Q3 | 24.0 million USD | 216.2 million USD |
| 2019Q2 | 27.5 million USD | 214.1 million USD |
| 2019Q1 | 19.2 million USD | 200.7 million USD |
| 2018Q4 | 22.8 million USD | 192.1 million USD |
| 2018Q3 | 19.3 million USD | 179.3 million USD |
| 2018Q2 | 16.6 million USD | 170.1 million USD |
| 2018Q1 | 14.6 million USD | 163.1 million USD |
| 2017Q4 | 11.3 million USD | 112.7 million USD |
| 2017Q3 | 9.8 million USD | 110.6 million USD |
| 2017Q2 | 9.6 million USD | 106.2 million USD |
| 2017Q1 | 8.4 million USD | 106.6 million USD |
| 2016Q4 | -21000 USD | 108.2 million USD |
| 2016Q3 | 5.0 million USD | 107.8 million USD |
| 2016Q2 | 5.0 million USD | 106.0 million USD |
| 2016Q1 | 3.4 million USD | 99.6 million USD |
| 2015Q4 | -8.6 million USD | 96.0 million USD |
| 2015Q3 | -133000 USD | 92.1 million USD |
| 2015Q2 | 95000 USD | 87.9 million USD |
| 2015Q1 | -59000 USD | 83.0 million USD |
| 2014Q4 | -15.6 million USD | 83.8 million USD |
| 2014Q3 | ? USD | 78.8 million USD |
| 2014Q2 | ? USD | 85.9 million USD |
| 2014Q1 | -1.2 million USD | 77.9 million USD |
MEDP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 282.8 million USD | 1.9 billion USD |
| 2022 | 245.4 million USD | 1.5 billion USD |
| 2021 | 181.8 million USD | 1.1 billion USD |
| 2020 | 145.4 million USD | 925.9 million USD |
| 2019 | 100.4 million USD | 861.0 million USD |
| 2018 | 73.2 million USD | 704.6 million USD |
| 2017 | 39.1 million USD | 436.2 million USD |
| 2016 | 13.4 million USD | 421.6 million USD |
| 2015 | -8.7 million USD | 359.1 million USD |
| 2014 | -15.6 million USD | 326.4 million USD |
| 2013 | 24.8 million USD | 272.9 million USD |
MEDP
Price: $385.70
52 week price:
Earnings Per Share: 9.81 USD
P/E Ratio: 36.32
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 218368
Ebitda: 28.9 millionMarket Capitalization: 12.2 billion